Zacks Investment Research on MSN
TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals
Shares of Tvardi Therapeutics TVRD nosedived 83.9% on Monday after the company provided a disappointing update following an ...
Beyond its initial phase II trial results, stroke therapy developer Argenica has identified a clear path forward based on new ...
The BoE designed its test to understand how interactions between banks and non-banks could amplify market shocks and threaten ...
GlobalData on MSN
Tvardi Therapeutics’ stock crashes on Phase II IPF flop
Tvardi Therapeutics’ stock has crashed more than 80% after the company revealed that its idiopathic pulmonary fibrosis (IPF) ...
Pulsar Helium (AIM: PLSR; TSXV: PLSR; WKNA3EP2C ) has mobilized a drill rig and associated equipment to its flagship Topaz ...
AstraZeneca furthers ambition to redefine cancer care with first data from four major pivotal trials at ESMO: Cambridge, UK Tuesday, October 14, 2025, 15:00 Hrs [IST] AstraZeneca ...
The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held October 22-26 in Boston, ...
Yet a new generation of public life sciences companies is rewriting that equation by diversifying not just products, but business models.
BRISTOL, TN / ACCESS Newswire / October 14, 2025 / Most biotech stories collapse on a single product failure. Medicus Pharma Ltd (NASDAQ:MDCX) built three distinct shots at blockbuster markets.The ...
Mineral Resource Estimate Confirms Pitfield's World Dominant Titanium Discovery Empire Metals Ltd., the AIM-quoted and OTCQX-traded exploration and development company, is pleased to report a maiden ...
Highest gram metre intercept to date at Glenburgh Gold Project HIGHLIGHTS: Lens 3 grows deeper and stronger with thickest ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果